PGGM Investments bought a new position in shares of Cigna Corporation (NYSE:CI) during the second quarter, according to its most recent disclosure with the SEC. The fund bought 128,968 shares of the health services provider’s stock, valued at approximately $21,588,000. PGGM Investments owned approximately 0.05% of Cigna Corporation as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. Kentucky Retirement Systems bought a new stake in Cigna Corporation during the fourth quarter worth about $2,485,000. Chevy Chase Trust Holdings Inc. raised its stake in Cigna Corporation by 3.3% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 222,948 shares of the health services provider’s stock worth $32,659,000 after buying an additional 7,057 shares during the last quarter. Fulton Bank N.A. bought a new stake in Cigna Corporation during the first quarter worth about $223,000. American Investment Services Inc. raised its stake in Cigna Corporation by 10.1% in the first quarter. American Investment Services Inc. now owns 2,183 shares of the health services provider’s stock worth $320,000 after buying an additional 200 shares during the last quarter. Finally, Gulf International Bank UK Ltd raised its stake in Cigna Corporation by 1.4% in the first quarter. Gulf International Bank UK Ltd now owns 79,827 shares of the health services provider’s stock worth $11,693,000 after buying an additional 1,085 shares during the last quarter. 86.91% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Cigna Corporation (NYSE:CI) traded down 0.20% during trading on Tuesday, hitting $175.63. 1,109,214 shares of the stock traded hands. The company has a market cap of $44.96 billion, a PE ratio of 23.45 and a beta of 0.46. The firm has a 50 day moving average price of $171.37 and a 200-day moving average price of $158.04. Cigna Corporation has a one year low of $115.03 and a one year high of $178.50.
Cigna Corporation (NYSE:CI) last posted its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.43. Cigna Corporation had a net margin of 7.46% and a return on equity of 17.58%. The company had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. During the same quarter in the previous year, the firm posted $1.98 EPS. The business’s revenue was up 3.6% compared to the same quarter last year. Analysts anticipate that Cigna Corporation will post $9.95 earnings per share for the current fiscal year.
CI has been the topic of a number of recent research reports. Zacks Investment Research raised Cigna Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday, April 11th. Jefferies Group LLC reiterated a “buy” rating and issued a $178.00 price target (up from $172.00) on shares of Cigna Corporation in a report on Sunday, April 23rd. Stifel Nicolaus boosted their price target on Cigna Corporation from $170.00 to $175.00 and gave the company a “buy” rating in a report on Friday, May 5th. Royal Bank Of Canada upped their price objective on Cigna Corporation from $172.00 to $177.00 and gave the stock an “outperform” rating in a report on Monday, May 8th. Finally, Deutsche Bank AG upped their price objective on Cigna Corporation from $172.00 to $175.00 and gave the stock a “buy” rating in a report on Wednesday, May 10th. Three research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company’s stock. Cigna Corporation presently has a consensus rating of “Buy” and a consensus target price of $179.89.
In other news, VP Mary T. Hoeltzel sold 500 shares of the business’s stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $166.70, for a total transaction of $83,350.00. Following the transaction, the vice president now owns 2,449 shares in the company, valued at approximately $408,248.30. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO David Cordani sold 153,168 shares of Cigna Corporation stock in a transaction dated Monday, June 19th. The shares were sold at an average price of $170.20, for a total transaction of $26,069,193.60. Following the sale, the chief executive officer now owns 421,162 shares in the company, valued at $71,681,772.40. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 219,558 shares of company stock worth $37,135,665. Insiders own 1.30% of the company’s stock.
About Cigna Corporation
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
